A retrospective observational study assessing frailty and clinical outcomes of direct oral anticoagulants versus warfarin in Older adults With atrial fibrillation
Latest Information Update: 27 Jul 2021
Price :
$35 *
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary) ; Warfarin
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- 27 Jul 2021 New trial record
- 20 Jul 2021 Results published in the Annals of Internal Medicine